147 related articles for article (PubMed ID: 32663573)
1. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.
Huang J; Huang LQ; He HS; Yan J; Huang C; Wang R; Guan Y; Huang DP
Life Sci; 2020 Sep; 257():118088. PubMed ID: 32663573
[TBL] [Abstract][Full Text] [Related]
2. Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells.
Wu W; Ma D; Wang P; Cao L; Lu T; Fang Q; Zhao J; Wang J
FEBS J; 2016 Mar; 283(5):834-49. PubMed ID: 26700310
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia.
Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J
Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830
[TBL] [Abstract][Full Text] [Related]
4. SDF-1/CXCR4 axis promotes osteogenic differentiation of BMSCs through the JAK2/STAT3 pathway.
Xiong W; Guo X; Cai X
Folia Histochem Cytobiol; 2021; 59(3):187-194. PubMed ID: 34580847
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor BG45-mediated HO-1 expression induces apoptosis of multiple myeloma cells by the JAK2/STAT3 pathway.
Tang S; Cheng B; Zhe N; Ma D; Xu J; Li X; Guo Y; Wu W; Wang J
Anticancer Drugs; 2018 Jan; 29(1):61-74. PubMed ID: 29049036
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.
Zhang Z; Wang W; Ma D; Xiong J; Kuang X; Zhang S; Fang Q; Wang J
Aging (Albany NY); 2020 Apr; 12(8):6611-6629. PubMed ID: 32298237
[TBL] [Abstract][Full Text] [Related]
8. Blockade of SDF-1/CXCR4 reduces adhesion-mediated chemoresistance of multiple myeloma cells via interacting with interleukin-6.
Liu Y; Liang HM; Lv YQ; Tang SM; Cheng P
J Cell Physiol; 2019 Nov; 234(11):19702-19714. PubMed ID: 30953364
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.
Yu K; Wang J; Lu T; Ma D; Wei D; Guo Y; Cheng B; Wang W; Fang Q
J Cell Biochem; 2019 Oct; 120(10):17791-17810. PubMed ID: 31264739
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells increase expression of heme oxygenase-1 leading to anti-inflammatory activity in treatment of acute liver failure.
Zhang ZH; Zhu W; Ren HZ; Zhao X; Wang S; Ma HC; Shi XL
Stem Cell Res Ther; 2017 Mar; 8(1):70. PubMed ID: 28320485
[TBL] [Abstract][Full Text] [Related]
13. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
Ren Z; Lantermans H; Kuil A; Kraan W; Arenzana-Seisdedos F; Kersten MJ; Spaargaren M; Pals ST
J Hematol Oncol; 2021 Jan; 14(1):11. PubMed ID: 33436043
[TBL] [Abstract][Full Text] [Related]
14. PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2/STAT3 pathway.
Kuang X; Xiong J; Wang W; Li X; Lu T; Fang Q; Wang J
Life Sci; 2019 Feb; 219():248-256. PubMed ID: 30658101
[TBL] [Abstract][Full Text] [Related]
15. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
[TBL] [Abstract][Full Text] [Related]
16. CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma.
Waldschmidt JM; Simon A; Wider D; Müller SJ; Follo M; Ihorst G; Decker S; Lorenz J; Chatterjee M; Azab AK; Duyster J; Wäsch R; Engelhardt M
Br J Haematol; 2017 Oct; 179(1):36-49. PubMed ID: 28670693
[TBL] [Abstract][Full Text] [Related]
17. As
Wu D; Dong W; Fang K; Wang M
Technol Cancer Res Treat; 2019; 18():1533033819896806. PubMed ID: 31868118
[TBL] [Abstract][Full Text] [Related]
18. Alleviation of apoptosis of bone marrow-derived mesenchymal stem cells in the acute injured kidney by heme oxygenase-1 gene modification.
Liu N; Wang H; Han G; Tian J; Hu W; Zhang J
Int J Biochem Cell Biol; 2015 Dec; 69():85-94. PubMed ID: 26456668
[TBL] [Abstract][Full Text] [Related]
19. Increased lncRNA HOTAIR expression promotes the chemoresistance of multiple myeloma to dexamethasone by regulating cell viability and apoptosis by mediating the JAK2/STAT3 signaling pathway.
Guan R; Wang W; Fu B; Pang Y; Lou Y; Li H
Mol Med Rep; 2019 Oct; 20(4):3917-3923. PubMed ID: 31485665
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells.
Feng Y; Wen J; Mike P; Choi DS; Eshoa C; Shi ZZ; Zu Y; Chang CC
Stem Cells Dev; 2010 Sep; 19(9):1289-96. PubMed ID: 20121456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]